Targeting β-Catenin Signaling by Natural Products for Cancer Prevention and Therapy

Area of Science:

• Oncology
• Molecular Biology
• Pharmacology

Background:

• Wnt signaling pathway deregulation and β-catenin activation are hallmarks of human cancers.
• Aberrant β-catenin contributes to cancer development and progression, making it a key therapeutic target.

Purpose of the Study:

• To comprehensively review natural product inhibitors of the β-catenin signaling pathway.
• To discuss their in vitro and in vivo anticancer activities and molecular mechanisms.
• To explore current and potential strategies for developing new β-catenin-targeting cancer drugs.

Main Methods:

• Literature review of natural products targeting the Wnt/β-catenin pathway.
• Analysis of studies reporting in vitro and in vivo anticancer efficacy.
• Examination of molecular mechanisms of inhibition.

Main Results:

• Numerous natural products inhibit β-catenin signaling via diverse mechanisms (e.g., degradation, nuclear translocation inhibition).
• These compounds demonstrate significant preventive and therapeutic potential in various cancer models.
• Established and novel molecular targets within the pathway are identified.

Conclusions:

• Natural products targeting β-catenin represent a promising avenue for cancer prevention and therapy.
• Further research into these compounds and targeting strategies could yield novel anticancer drugs.
• Understanding molecular mechanisms is crucial for drug development.